Comparison Hub · 2026
REMEVi vs. every GLP-1 telehealth provider
Honest, side-by-side comparisons of REMEVi against other semaglutide and tirzepatide providers — on price, bilingual support, pricing transparency, and what's actually included. No spin: where a competitor is cheaper, we say so.
Side-by-side
Choose a provider to compare
Each page breaks down pricing, Spanish-language support, response time, and what's included — based on publicly available data, updated June 2026.
REMEVi vs Hims / Hers
Native bilingual care and transparent all-inclusive pricing vs the biggest name in telehealth.
See the comparisonREMEVi vs Ro
How REMEVi compares to Ro on price, bilingual support, and response time.
See the comparisonREMEVi vs Medvi
Lower ongoing pricing and native bilingual care vs Medvi’s first-month rates.
See the comparisonREMEVi vs Mochi Health
One all-inclusive price with no separate membership fee vs Mochi Health.
See the comparisonREMEVi vs Remedy Meds
Lower, fully published pricing and bilingual care vs Remedy Meds.
See the comparisonREMEVi vs TrimRx
Transparent monthly pricing with no 12-month lock-in vs TrimRx.
See the comparisonREMEVi vs Yucca Health
Pricing published upfront and native bilingual care vs Yucca Health.
See the comparisonREMEVi vs Eden
Transparent pricing that stays flat at every dose vs Eden.
See the comparisonREMEVi vs Ivy Rx
Native bilingual care and transparent pricing vs Ivy Rx.
See the comparisonREMEVi vs Gimme Care
Dedicated bilingual support and nationwide licensing vs Gimme Care.
See the comparisonREMEVi vs Good Life Meds
Lower tirzepatide pricing and native bilingual care vs Good Life Meds.
See the comparisonHow we compare providers
Every comparison uses each provider's publicly advertised pricing and program details as of June 2026, with competitor figures hedged and a note to verify current pricing on their own site. We don't claim REMEVi is cheaper when it isn't — several providers advertise lower headline prices, and we say so plainly.
Where REMEVi consistently differs: native bilingual English and Spanish care with a dedicated care coordinator, all-inclusive pricing with no separate membership or dose upcharge, and licensing across all 50 states plus DC. Compounded medications are non-FDA-approved preparations prepared by state-licensed compounding pharmacies and are not generic versions of, nor the same as, Ozempic®, Wegovy®, Mounjaro®, or Zepbound®.
Ready to get started with REMEVi?
Clinical review in 24 hours. No insurance needed. a flat $219/mo ($149/mo on the 52-week plan), all-inclusive.
See if you qualify